The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)–Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) working group provided updates at the 2019 GRAPPA annual meeting on its work toward developing a core outcome set for PsA. The working group prioritized 4 domains, including musculoskeletal disease activity (enthesitis and dactylitis), fatigue, physical function, and structural damage. In this report, the working group summarizes its progress in standardizing the core outcome set for these 4 domains.

Contributors

Ying Ying Leung, William Tillett, Ana-Maria Orbai, Alexis Ogdie, Lihi Eder, Laura C. Coates, Richard Holland, Anna Antony, Niti Goel, Philip J. Mease, Vibeke Strand, Oliver FitzGerald, Maarten de Wit, Christine A. Lindsay, Kristina Callis Duffin and Dafna D. Gladman

Publication

Journal: The Journal of Rheumatology Supplement
Volume: 96
Issue:
Pages: 46 - 49
Year: 2020
DOI: 10.3899/jrheum.200127

Further Study Information

Current Stage: Completed
Date:
Funding source(s):

---

Method(s)

Linked Studies

• International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
• Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods
• Consensus on a core set of domains for psoriatic arthritis
• OMERACT 7 psoriatic arthritis workshop: synopsis
• Consensus exercise on domains in psoriatic arthritis
• Review of the Psoriatic Arthritis Working Group at OMERACT 12: A Report from the GRAPPA 2014 Annual Meeting
• Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014
• Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set
• Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016
• Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group
• A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative
• Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
• Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis
• Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 Psoriatic Arthritis workshop report
• Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group
• Composite Outcome Measures for Psoriatic Arthritis: OMERACT and 3 and 4 Visual Analog Scale Progress in 2023

Related Links

No related links